Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China flag China · Delayed Price · Currency is CNY
51.41
-0.06 (-0.12%)
Aug 25, 2026, 3:04 PM CST

SHE:300832 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,454997.44919.531,048483.43617.58
Short-Term Investments
1,2771,12675275.79110.09-
Trading Asset Securities
678.591,2671,7232,0802,8142,806
Cash & Short-Term Investments
3,4103,3902,7183,4043,4073,424
Cash Growth
99.86%24.74%-20.16%-0.09%-0.49%1.46%
Accounts Receivable
1,0031,001957.49631.78479.97276.1
Other Receivables
273.4239.52147.9880.6642.8312.69
Receivables
1,2771,2401,105712.44522.79288.79
Inventory
1,0481,0401,198916.79839.33645.38
Prepaid Expenses
11.6511.6723.727.4432.29104.75
Other Current Assets
12.711.6110.7523.0920.834.16
Total Current Assets
5,7605,6945,0565,0644,8224,497
Property, Plant & Equipment
1,8031,7631,6941,4421,3251,134
Long-Term Investments
1,1781,5311,974924.95357.62136.9
Other Intangible Assets
230.18237.39245.06169.46172.4894.56
Long-Term Accounts Receivable
413.04392.46310.8189.1793.8528.1
Long-Term Deferred Tax Assets
99.7787.3563.9837.9422.912.14
Long-Term Deferred Charges
112.86125.73150.83156.6969.0874.97
Other Long-Term Assets
166.89109.79124.8238.22150.77157.39
Total Assets
9,7649,9419,6198,2227,0156,136

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
199.23152.11456.62126.99176.68171.35
Accrued Expenses
199.96222.03200.59187.77149.03124.27
Current Portion of Leases
1.981.821.341.691.321.35
Current Income Taxes Payable
91.9898.3120.14120.3576.1959.92
Current Unearned Revenue
70.4887.7380.1391.48108.9477.08
Other Current Liabilities
67.3871.8949.9163.271.7873.96
Total Current Liabilities
631.02633.89908.74591.48583.94507.94
Long-Term Leases
1.321.862.763.490.890.88
Long-Term Unearned Revenue
43.2546.4347.2633.065.816.58
Long-Term Deferred Tax Liabilities
112.19106.9778.5150.0624.418.11
Other Long-Term Liabilities
7.026.765.58---
Total Liabilities
794.8795.911,043678.09615.06523.51

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
785.72785.72785.72785.72786.13786.66
Additional Paid-In Capital
1,3321,3321,3321,3321,3481,450
Retained Earnings
6,9437,0166,4175,3744,2673,411
Treasury Stock
-100----16.29-37.51
Comprehensive Income & Other
8.2711.1441.7252.713.991.64
Shareholders' Equity
8,9699,1458,5777,5446,3995,612
Total Liabilities & Equity
9,7649,9419,6198,2227,0156,136

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
3.33.684.15.182.222.24
Net Cash (Debt)
3,4073,3872,7143,3993,4053,422
Net Cash Growth
100.13%24.79%-20.16%-0.17%-0.49%1.40%
Net Cash Per Share
4.344.313.454.334.334.35
Filing Date Shares Outstanding
785.72785.72785.72785.72786.13786.66
Total Common Shares Outstanding
785.72785.72785.72785.72786.13786.66
Working Capital
5,1285,0604,1474,4734,2383,989
Book Value Per Share
11.4211.6410.929.608.147.13
Tangible Book Value
8,7398,9078,3327,3756,2275,517
Tangible Book Value Per Share
11.1211.3410.609.397.927.01
Buildings
1,0611,0611,0611,061541.55516.8
Machinery
906.86887.94811.8659.08512.48427.32
Construction In Progress
649.15549.45414.56169.32605.7442.99